CPhI & P-MEC China 2020 stimulates partnerships across pharma supply chain

Pharma |  News | 0 Comment | 21 Jan, 2021

The recently hosted CPhI & P-MEC China 2020 – organised by Informa Markets and CCCMHPIE and co-organised by Sh...Read more

Cytiva delivers modular biologics factory to Lonza in China

Pharma |  News | 0 Comment | 14 Jan, 2021

Cytiva, a global life sciences leader, has successfully completed another KUBio installation, this time to global health...Read more

FarmaTrust calls on UK govt to implement blockchain for drug security

Pharma |  News | 0 Comment | 13 Jan, 2021

The UK is now facing a significant problem in how it secures the country’s medicines’ supply chain after lea...Read more

Fujifilm to invest $40M in innovative viral vector and advanced therapy facility

Pharma |  News | 0 Comment | 05 Jan, 2021

Japan's FUJIFILM Corporation is making a major capital investment of approximately 4 billion yen ($40 mil...Read more

Lynparza receives three new approvals for cancer treatment in Japan

Pharma |  News | 0 Comment | 29 Dec, 2020

AstraZeneca and Merck, known as MSD outside the United States and Canada, have announced that LYNPARZA has been approved...Read more

China makes new inclusions in national reimbursement drug list

Pharma |  News | 0 Comment | 28 Dec, 2020

BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative medicines w...Read more

Foresee Pharma completes $47 M financing to support drug research

Pharma |  News | 0 Comment | 28 Dec, 2020

Foresee Pharmaceuticals, a Taiwan and US-based biopharmaceutical company, announces that it has successfu...Read more

Eisai strengthens in-house production function for anti-cancer drugs

Pharma |  News | 0 Comment | 24 Dec, 2020

Eisai Co., Ltd. has announced that it has completed construction of the 5th manufacturing building at the Kawashima Indu...Read more

NovoNordisk’s Rybelsus could be a game-changer in Type 2 Diabetes

Pharma |  News | 0 Comment | 23 Dec, 2020

NovoNordisk’s decision to investigate its recently launched Type 2 Diabetes (T2D) drug Rybelsus (semaglutide) in a...Read more

WuXi Biologics acquires drug substance facility from Bayer

Pharma |  News | 0 Comment | 24 Dec, 2020

WuXi Biologics, a global company with leading open-access biologics technology platforms, and Bayer, have announced an a...Read more

Hyundai Bioscience develops injection drug for COVID-19 treatment

Pharma |  News | 0 Comment | 23 Dec, 2020

Hyundai Bioscience has announced that CNPharm, its major shareholding biotech company, has succeeded in developing 'Poly...Read more

Dr Reddy’s Canada files application for favipiravir tablets

Pharma |  News | 1 Comment | 22 Dec, 2020

Indian pharmaceutical firm Reddy’s Laboratories Ltd, Appili Therapeutics and Global Response Aid FZCO&nb...Read more

Alterity, UniQuest team up to reverse bacterial resistance to antibiotics

Pharma |  News | 0 Comment | 22 Dec, 2020

Alterity Therapeutics has announced it has been granted a licence by UniQuest, the commercialisation company of The ...Read more

Takeda sells select non-core assets to Chinese firm for $322 M

Pharma |  News | 0 Comment | 21 Dec, 2020

Takeda Pharmaceutical Company, headquartered in Japan, has announced that it has entered into an agreement to divest a p...Read more

Singapore approves extended-release analgesic injection by Lumosa

Pharma |  News | 0 Comment | 21 Dec, 2020

Lumosa, based in Taiwan, has announced the market approval of LT1001 (Naldebain®), an extended-release analgesic i...Read more

Alvotech and Fuji Pharma extend biosimilar partnership in Japan

Pharma |  News | 0 Comment | 16 Dec, 2020

Alvotech and Japanese pharmaceutical company Fuji Pharma have announced that they have agreed on an extension on their e...Read more

GlobalData reveals role of Japan’s immunology market in branded digital marketing space

Pharma |  Analysis | 0 Comment | 15 Dec, 2020

The Japanese immunology market is highly competitive with many innovator products available for rheumatoid arthritis (RA...Read more

AstraZeneca to acquire Alexion for $39B

Pharma |  News | 0 Comment | 15 Dec, 2020

British multinational AstraZeneca and US based Alexion Pharmaceuticals, Inc. have entered into a definitive agreement fo...Read more